The global ENT devices market size is anticipated to reach USD 37.72 billion by 2030, growing at a CAGR of 5.54% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth can be attributed to factors such as a rising geriatric population, high prevalence of hearing loss, and increasing penetration of minimally invasive surgeries. Technological advancements in this field, an increase in healthcare investment for early detection of diseases, and favorable regulatory policies are other factors expected to drive the market’s growth.
The risk of poor immunity increases with age, making older people more vulnerable to disorders of the nose and throat. To address this issue, elderly people need regular check-ups for ENT disorders, which is leading to a rise in demand for ENT devices. According to the Royal National Institute for Deaf People (RNID), over 12 million people in the UK suffered from hearing loss. Out of these, over 40% of people were in the 50s & above, and more than 70% of people were in the 70s & above.
Hearing loss is a common chronic physical condition affecting the people of all ages. It is the third-most common condition after high blood pressure and arthritis. It is more prevalent in elder population, particularly in people over 65 years of age, and 1 in 3 people are likely to suffer from a disabling hearing loss. It can negatively impact communication and leading to depression, anxiety, social isolation, and cognitive decline. According to the National Institute on Deafness and Other Communication Disorders, 15% of the total U.S. population over 18 years of age are likely to have a hearing impairment. In addition, men are more likely to be affected with hearing loss than women.
Request a free sample copy or view report summary: ENT Devices Market Report
Based on product type, hearing aids held the largest revenue share of over 30% in 2023 and is estimated to grow at the fastest CAGR from 2024 to 2030, owing to the increasing adoption of hearing aids devices and the prevalence of hearing loss due to the growing geriatric population
The hearing implants segment is expected to grow at the second fastest CAGR over the forecast period.This can be attributed to the increasing adoption of hearing implants, rising awareness about cochlear implants as non-invasive procedures
North America dominated the market in 2023, due to several factors such as increased demand for hearing care devices, the presence of large hospital chains, highly equipped ambulatory facilities, and a significant target population
In February 2023, Innovia Medical launched the Summit of Medical ENT product range at BACO International 2023 held in the UK. The product range featured various premium essentials, including Ventilation Tubes and Grommets, Denver Splint, AbsorbENT Nasal and Sinus Packs, and Rhino Rocket
Grand View Research has segmented the global ENT devices market based on product and region:
ENT Devices Product Outlook (Revenue, USD Million, 2018 - 2030)
Diagnostic ENT Devices
Rigid Endoscopes
Sinuscopes
Otoscopes
Laryngoscopes
Flexible Endoscopes
Bronchoscopes
Laryngoscopes
Nasopharyngoscopes
Robot Assisted Endoscope
Hearing Screening Device
Surgical ENT Devices
Radiofrequency handpieces
Otological Drill Burrs
ENT Hand Instruments
Sinus Dilation Devices
Nasal Packing Devices
Hearing Aids
Hearing Implants
Nasal Splints
ENT Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East & Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the ENT Devices Market
Ambu A/S
Cochlear Ltd.
Demant A/S
GN Store Nord A/S
Karl Storz
Olympus Corporation
PENTAX Medical
Richard Wolf GmbH
Rion Co., Ltd.
Smith & Nephew plc
Sonova
Starkey Laboratories, Inc.
Stryker
Nico Corporation
Nemera
"The quality of research they have done for us has been excellent..."